M. W. O'Halloran

469 total citations
29 papers, 354 citations indexed

About

M. W. O'Halloran is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, M. W. O'Halloran has authored 29 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Nephrology, 4 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Genetics. Recurrent topics in M. W. O'Halloran's work include Thyroid Disorders and Treatments (4 papers), Renal function and acid-base balance (3 papers) and Bone health and treatments (2 papers). M. W. O'Halloran is often cited by papers focused on Thyroid Disorders and Treatments (4 papers), Renal function and acid-base balance (3 papers) and Bone health and treatments (2 papers). M. W. O'Halloran collaborates with scholars based in Australia, United Kingdom and Barbados. M. W. O'Halloran's co-authors include M.L. Wellby, Martin Wellby, K.V. Johny, Anthony Pohl, P R Pannall, John S. Coon, Zhenghong Lin, Peihao Yin, Gökhan M. Mutlu and Serdar E. Bulun and has published in prestigious journals such as Nature, Oncogene and British Journal Of Nutrition.

In The Last Decade

M. W. O'Halloran

28 papers receiving 303 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. W. O'Halloran Australia 11 56 53 51 35 33 29 354
B. H. Ershoff United States 11 62 1.1× 47 0.9× 75 1.5× 102 2.9× 22 0.7× 49 418
L Wenda-Rózewicka Poland 11 103 1.8× 108 2.0× 16 0.3× 24 0.7× 19 0.6× 23 370
Razia Sultana Mohammad India 6 150 2.7× 38 0.7× 78 1.5× 14 0.4× 20 0.6× 10 363
William M. Doizaki United States 12 154 2.8× 43 0.8× 59 1.2× 79 2.3× 12 0.4× 23 499
E Havivi Israel 11 86 1.5× 48 0.9× 72 1.4× 186 5.3× 13 0.4× 30 436
Antero Julkunen Finland 10 95 1.7× 78 1.5× 85 1.7× 214 6.1× 28 0.8× 16 506
David C. Herting United States 12 88 1.6× 46 0.9× 111 2.2× 156 4.5× 4 0.1× 21 537
Paquita González Spain 8 96 1.7× 20 0.4× 28 0.5× 33 0.9× 24 0.7× 16 254
Jürgen Müller Germany 13 119 2.1× 65 1.2× 24 0.5× 17 0.5× 27 0.8× 32 348
Alan I. Fleischman United States 14 52 0.9× 72 1.4× 101 2.0× 134 3.8× 13 0.4× 28 460

Countries citing papers authored by M. W. O'Halloran

Since Specialization
Citations

This map shows the geographic impact of M. W. O'Halloran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. W. O'Halloran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. W. O'Halloran more than expected).

Fields of papers citing papers by M. W. O'Halloran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. W. O'Halloran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. W. O'Halloran. The network helps show where M. W. O'Halloran may publish in the future.

Co-authorship network of co-authors of M. W. O'Halloran

This figure shows the co-authorship network connecting the top 25 collaborators of M. W. O'Halloran. A scholar is included among the top collaborators of M. W. O'Halloran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. W. O'Halloran. M. W. O'Halloran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Zhenghong, Peihao Yin, M. W. O'Halloran, et al.. (2009). Adenosine A1 receptor, a target and regulator of estrogen receptorα action, mediates the proliferative effects of estradiol in breast cancer. Oncogene. 29(8). 1114–1122. 57 indexed citations
2.
Ratnaike, Ranjit N., et al.. (1983). Erythrocyte Ammonia in Liver Disease. Scandinavian Journal of Gastroenterology. 18(1). 103–106. 2 indexed citations
3.
Pohl, Anthony, M. W. O'Halloran, & P R Pannall. (1981). BIOCHEMICAL AND PHYSIOLOGICAL CHANGES IN FOOTBALL PLAYERS. The Medical Journal of Australia. 1(9). 467–470. 24 indexed citations
4.
O'Halloran, M. W., et al.. (1980). Fetal Cephalometry in an Australian Population. Australasian Radiology. 24(1). 59–61. 1 indexed citations
5.
Gilligan, Bernard S., Jack Wodak, RD Stark, & M. W. O'Halloran. (1979). Comparison of enteric-coated levodopa with levodopa-carbidopa combination. A double-blind crossover trial.. PubMed. 2(4). 205–7. 1 indexed citations
6.
Wellby, M.L., et al.. (1973). A comparison of effective thyroxine ratio and free thyroxine in serum. Clinica Chimica Acta. 45(3). 255–259. 11 indexed citations
7.
Thomas, E, Eileen S. Hackett, M. W. O'Halloran, Ian Hislop, & A. Kerr Grant. (1972). AN EVALUATION OF THE SECRETIN TEST IN CHRONIC PANCREATIC DISEASE. The Medical Journal of Australia. 1(17). 860–863. 1 indexed citations
8.
O'Halloran, M. W., et al.. (1972). Daily fluctuations in mean value of quality control sera and the daily means of truncated patient test results. Pathology. 4(2). 155–155. 1 indexed citations
9.
Johny, K.V., et al.. (1971). Effect of Haemodialysis on Erythrocyte and Plasma Potassium, Magnesium, Sodium and Calcium. ˜The œNephron journals/Nephron journals. 8(1). 81–90. 5 indexed citations
10.
Johny, K.V., et al.. (1970). A Whole Body Counter for Serial Studies of Total Body Potassium. Clinical Science. 39(2). 319–326. 6 indexed citations
11.
Johny, K.V., et al.. (1970). Studies on Total Body, Serum and Erythrocyte Potassium in Patients on Maintenance Haemodialysis. The Value of Erythrocyte Potassium as a Measure of Body Potassium. ˜The œNephron journals/Nephron journals. 7(3). 230–240. 19 indexed citations
12.
O'Halloran, M. W., et al.. (1970). A comparison of conventionally derived normal ranges with those obtained from patients' results. Clinica Chimica Acta. 27(1). 35–46. 23 indexed citations
13.
O'Halloran, M. W. & M.L. Wellby. (1966). Recoveries of Iodine-131-labelled Iodo-amino-acids in the Plasma Protein-bound Iodine Assay. Nature. 211(5054). 1195–1197. 3 indexed citations
14.
Wellby, M.L. & M. W. O'Halloran. (1966). THE VALUE OF PROTEIN‐BOUND IODINE AND TRIIODOTHYRONINE RESIN UPTAKE IN ASSESSING THYROID FUNCTION. Australasian Annals of Medicine. 15(2). 116–121. 3 indexed citations
15.
O'Halloran, M. W.. (1962). The effect of oxalate on bacteria isolated from the rumen.. 2 indexed citations
16.
O'Halloran, M. W., et al.. (1962). THE EFFECT OF COBALT BULLET TREATMENT OF HEREFORD COWS ON THE BIRTH WEIGHT AND GROWTH RATE OF THEIR CALVES. Australian Veterinary Journal. 38(3). 98–102. 8 indexed citations
17.
O'Halloran, M. W., et al.. (1962). THE EFFECT OF COBALT BULLET TREATMENT OF HEREFORD COWS ON THE BIRTH WEIGHT AND GROWTH RATE OF THEIR CALVES. Australian Veterinary Journal. 38(3). 98–102. 4 indexed citations
18.
O'Halloran, M. W., et al.. (1961). THE EFFECT OF COBALT BULLETS ON MILK PRODUCTION OF DAIRY CATTLE. Australian Veterinary Journal. 37(5). 181–184. 5 indexed citations
19.
Sutherland, A. K., et al.. (1959). The correction of cobalt or vitamin B12 deficiency in cattle by cobalt pellet therapy.. American Journal of Veterinary Research. 20. 977–984. 17 indexed citations
20.
Day, Anthony J., et al.. (1959). THE EFFECT OF THE ANTIOXIDANT BUTYLATED HYDROXY TOLUENE ON SERUM LIPID AND GLYCOPROTEIN LEVELS IN THE RAT. Immunology and Cell Biology. 37(3). 295–306. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B. H. Ershoff Breakdown of academic impact, for papers by L Wenda-Rózewicka Breakdown of academic impact, for papers by Razia Sultana Mohammad Breakdown of academic impact, for papers by William M. Doizaki Breakdown of academic impact, for papers by E Havivi Breakdown of academic impact, for papers by Antero Julkunen Breakdown of academic impact, for papers by David C. Herting Breakdown of academic impact, for papers by Paquita González Breakdown of academic impact, for papers by Jürgen Müller Breakdown of academic impact, for papers by Alan I. Fleischman
Rankless by CCL
2026